Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Allurion Technologies, Inc.

< Previous 1 2 Next >
Allurion Reports First Quarter 2024 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Preliminary First Quarter 2024 Results
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Expands Virtual Care Suite to the United States
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Participate in Cowen’s 44th Annual Health Care Conference
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Participate in the Jefferies London Healthcare Conference
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion to Report Third Quarter 2023 Financial Results on November 13, 2023
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion Balloon
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Announces Acceptance of Five Abstracts for Presentation at Obesity Week 2023
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Featured at the 2023 International Bariatric Club Oxford University World Congress
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Introduces Coach Iris: A 24/7 Generative AI-Powered Weight Loss Coach
From Allurion Technologies, Inc.
Via Business Wire
Tickers ALUR
Allurion Debuts as a Publicly Traded Company on the NYSE
From Allurion Technologies, Inc.
Via Business Wire
Tickers CPUH
Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion
From Allurion Technologies, Inc.
Via Business Wire
Tickers CPUH
Compute Health Acquisition Corp. Warrant Holders Hold Special Meeting
From Allurion Technologies, Inc.
Via Business Wire
Tickers CPUH
Allurion Announces New Additions to Board of Directors and Executive Leadership Team
From Allurion Technologies, Inc.
Via Business Wire
Tickers CPUH
Allurion Technologies, Inc. and Compute Health Acquisition Corp. Remind Stockholders to Vote in Favor of Proposed Business Combination
From Allurion Technologies, Inc.
Via Business Wire
Tickers CPUH
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.